Correlation of hyper-homocysteinemia with coronary artery disease in absence of conventional risk factors among young adults

World Health Organization. Available at: http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds); May 17, 2017. Mangge, 2014, Antioxidants, inflammation, and cardiovascular disease, World J Cardiol, 6, 462, 10.4330/wjc.v6.i6.462 Santulli, 2013, Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts, J Cardiovasc Dis, 1, 1 Shenoy, 2014, Correlation of serum homocysteine levels with the severity of coronary artery disease, Indian J Clin Biochem, 29, 339, 10.1007/s12291-013-0373-5 Jiangping, 2013, Assessment of coronary artery stenosis by coronary angiography: a head-to-head comparison with pathological coronary artery anatomy, Circ Cardiovasc Interv, 6, 262, 10.1161/CIRCINTERVENTIONS.112.000205 Baszczuk, 2013, Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia, Postepy higieny i medycyny doswiadczalnej, 68, 91, 10.5604/17322693.1087521 Karolczak, 2013, Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study, Pharmacol Res, 74, 7, 10.1016/j.phrs.2013.04.010 Schaffer, 2014, Relationship between homocysteine and coronary artery disease: results from a large prospective cohort study, Thromb Res, 134, 288, 10.1016/j.thromres.2014.05.025 Mahalle, 2013, Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease, J Cardiol, 61, 289, 10.1016/j.jjcc.2012.11.009 Ganguly, 2015, Role of homocysteine in the development of cardiovascular disease, Nutr J, 14, 6, 10.1186/1475-2891-14-6 Liu, 2014, The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials, Atherosclerosis, 235, 31, 10.1016/j.atherosclerosis.2014.03.032 La’ulu, 2008, Performance characteristics of six homocysteine assays, Am J Clin Pathol, 130, 969, 10.1309/AJCP64BJIPNPSQDJ Silvia, 2004, Analytical performance and method comparison of total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer, Clin Chem Med, 42, 228 Weiss, 2002, Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia, Vasc Med, 7, 227, 10.1191/1358863x02vm428ra Pitla, 2009, Gender-related differences in the relationship between plasma homocysteine, anthropometric, and conventional biochemical coronary heart disease risk factors in middle-aged Indians, Ann Nutr Metab, 54, 1, 10.1159/000199452 Bianca, 2013, Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia, Proc Natl Acad Sci USA, 110, 15812, 10.1073/pnas.1309049110 Catena, 2015, Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension, J Am Soc Hypertens, 9, 167, 10.1016/j.jash.2014.12.020 Pang, 2014, Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells, Atherosclerosis, 236, 73, 10.1016/j.atherosclerosis.2014.06.021 Veeranna, 2011, Homocysteine and reclassification of cardiovascular disease risk, J Am Coll Cardiol, 58, 1025, 10.1016/j.jacc.2011.05.028 Zhang, 2014, Association between serum homocysteine and arterial stiffness in elderly: a community-based study, J Geriatr Cardiol, 11, 32 Mendis, 2011, Hyperhomocysteinaemia in Sri Lankan patients with coronary artery disease, Ceylon Med J, 47, 89, 10.4038/cmj.v47i3.3436 2002, Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis, JAMA, 288, 2015, 10.1001/jama.288.16.2015 Babu, 2015, Myriad cardiac manifestation of hyperhomocysteinemia, Cardiol Res, 6, 263, 10.14740/cr395w Yeh, 2017, Impact of homocysteine level on long-term cardiovascular outcomes in patients after coronary artery stenting, J Atheroscler Thromb, 24, 696, 10.5551/jat.36434 Moustapha, 1999, Prevalence and determinants of hyperhomocystenemia in hemodialysis and peritoneal dialysis, Kidney Int, 55, 1470, 10.1046/j.1523-1755.1999.00378.x Iqbal, 2006, Hyperhomocysteinemia and coronary artery disease in Pakistan, J Pak Med Assoc, 56, 282 Zafar F, Idress MM, Aimed Z. Prevalence of enteric infection in suburban Karachi: a study focused on Landhi-Kolangi area. International Nutritional Conference 2004. Nutrition Association of Pakistan, Lahore, 157(abstract). https://www.ejmanager.com/mnstemps/27/27-1301828620.pdf.